

biotech companies tackling today’s biggest challenges.
Simoa Session: Ultra-Sensitive Biomarker Detection from Discovery to the Clinic
Join the Quanterix team at MBC BioLabs for a Lunch & Learn focused on accelerating biomarker discovery through ultra-sensitive protein detection, custom assay development, and translational research support. This session will highlight how biotech teams are leveraging Quanterix Accelerator Lab Services to develop and validate custom biomarker assays, generate high sensitivity protein data, and transition assays into their own workflows using the Simoa SR-X platform. We’ll discuss how researchers can move from exploratory biomarker questions to scalable in-house testing workflows through Quanterix’s CARe program, enabling long term flexibility for translational and clinical research programs.
Topics will include:
Quanterix Accelerator Lab capabilities and workflows
Translating assay development onto the Simoa SR-X for onsite use at MBC Biolabs
Applications in translational research, immunology, neurology, oncology, and more
Custom assay development and biomarker strategy support
Interactive Q&A with the Quanterix scientific team
Agenda:
12:00 PM to 12:25 PM – Jorge Marques Signes
12:25 PM to 12:50 PM – Mingwei Zhao
12:50 PM to 1:00 PM - Open Q&A with the Quanterix team
biotech companies tackling today’s biggest challenges.